Veranex
Scott Huennekens is an accomplished executive with a diverse background in leadership roles across multiple companies. Currently serving as Executive Chairperson of the Board at Elucid and On Target Laboratories, Scott also holds board memberships at Veranex, Proximie, Q'Apel Medical, Inc., and Foldax Inc., among others. Since January 2019, Scott has been the Principal at Front Foot Ventures and, since September 2019, the Chairperson of the Board at Envista Holdings Corporation. Additionally, Scott has served as Chairperson of the Board at Hyperfine and KARDION GmbH. Educational credentials include a Master of Business Administration in Entrepreneurship/Entrepreneurial Studies from Harvard Business School and a Bachelor's degree in Business with an emphasis in Accounting from the University of Southern California.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Veranex
6 followers
Veranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment across the four concept-to-commercialization pillars — engineering and design, regulatory, clinical, and market access.